- Home
- PLBC vs OABI Comparison
PLBC vs OABI Comparison
Compare PLBC & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PLBC | OABI |
|---|---|---|
| Founded | 1980 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 288.9M | 239.0M |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | PLBC | OABI |
|---|---|---|
| Price | $43.95 | $1.95 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $55.00 | $6.67 |
| AVG Volume (30 Days) | 13.3K | ★ 547.4K |
| Earning Date | 01-14-2026 | 11-04-2025 |
| Dividend Yield | ★ 2.74% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.23 | N/A |
| Revenue | ★ $89,868,000.00 | $21,094,000.00 |
| Revenue This Year | $21.11 | N/A |
| Revenue Next Year | $16.11 | $66.19 |
| P/E Ratio | $10.36 | ★ N/A |
| Revenue Growth | ★ 12.51 | 3.36 |
| 52 Week Low | $38.71 | $1.22 |
| 52 Week High | $50.45 | $4.17 |
Technical Indicators
Market Signals| Indicator | PLBC | OABI |
|---|---|---|
| Relative Strength Index (RSI) | 59.94 | 66.48 |
| Support Level | $42.02 | $1.69 |
| Resistance Level | $44.51 | $1.64 |
| Average True Range (ATR) | 0.93 | 0.12 |
| MACD | 0.21 | 0.03 |
| Stochastic Oscillator | 73.95 | 98.18 |
Price Performance
Historical ComparisonAbout PLBC Plumas Bancorp
Plumas Bancorp provides various banking products and services in Northeastern California and Northwestern Nevada. It provides various deposit products such as checking, interest-bearing checking, business sweep, public funds sweep, savings, time deposit, and retirement accounts. The bank's loan portfolio consists of commercial real estate loans; commercial and industrial loans; consumer loans; agricultural loans; residential real estate loans, and construction and land development loans. The bank generates revenue from loans and investment securities in its portfolio and, to a lesser extent, service fees.
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.